Literature DB >> 25712186

Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas.

Elizabeth H Dorfman1, Susan Brown Trinidad, Chelsea T Morales, Kevin Howlett, Wylie Burke, Erica L Woodahl.   

Abstract

AIM: The limited formal study of the clinical feasibility of implementing pharmacogenomic tests has thus far focused on providers at large medical centers in urban areas. Our research focuses on small metropolitan, rural and tribal practice settings. MATERIALS &
METHODS: We interviewed 17 healthcare providers in western Montana regarding pharmacogenomic testing.
RESULTS: Participants were optimistic about the potential of pharmacogenomic tests, but noted unique barriers in small and rural settings including cost, adherence, patient acceptability and testing timeframe. Participants in tribal settings identified heightened sensitivity to genetics and need for community leadership approval as additional considerations.
CONCLUSION: Implementation differences in small metropolitan, rural and tribal communities may affect pharmacogenomic test adoption and utilization, potentially impacting many patients. Original submitted 3 September 2014; Revision submitted 3 December 2014.

Entities:  

Keywords:  Alaska Native; American Indian; implementation; indigenous populations; pharmacogenetics; pharmacogenomics; rural

Mesh:

Year:  2015        PMID: 25712186      PMCID: PMC4360986          DOI: 10.2217/pgs.14.174

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  34 in total

1.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.

Authors:  M V Relling; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

2.  The path to personalized medicine.

Authors:  Margaret A Hamburg; Francis S Collins
Journal:  N Engl J Med       Date:  2010-06-15       Impact factor: 91.245

3.  The potential impact of pharmacogenetic testing on medication adherence.

Authors:  S B Haga; N M A LaPointe
Journal:  Pharmacogenomics J       Date:  2013-09-03       Impact factor: 3.550

4.  Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.

Authors:  S B Haga; J M O'Daniel; G M Tindall; R Mills; I M Lipkus; R Agans
Journal:  Clin Genet       Date:  2012-02-19       Impact factor: 4.438

5.  Making pharmacogenetic testing a reality in a community pharmacy.

Authors:  Shanna K O'Connor; Stefanie P Ferreri; Natasha M Michaels; Rebecca W Chater; Anthony J Viera; Hawazin Faruki; Howard L McLeod; Mary Roederer
Journal:  J Am Pharm Assoc (2003)       Date:  2012

6.  Public perspectives about pharmacogenetic testing and managing ancillary findings.

Authors:  Susanne B Haga; Genevieve Tindall; Julianne M O'Daniel
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-02

7.  A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Authors:  Stephen E Kimmel; Benjamin French; Scott E Kasner; Julie A Johnson; Jeffrey L Anderson; Brian F Gage; Yves D Rosenberg; Charles S Eby; Rosemary A Madigan; Robert B McBane; Sherif Z Abdel-Rahman; Scott M Stevens; Steven Yale; Emile R Mohler; Margaret C Fang; Vinay Shah; Richard B Horenstein; Nita A Limdi; James A S Muldowney; Jaspal Gujral; Patrice Delafontaine; Robert J Desnick; Thomas L Ortel; Henny H Billett; Robert C Pendleton; Nancy L Geller; Jonathan L Halperin; Samuel Z Goldhaber; Michael D Caldwell; Robert M Califf; Jonas H Ellenberg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

8.  Ethical issues in developing pharmacogenetic research partnerships with American Indigenous communities.

Authors:  B B Boyer; D Dillard; E L Woodahl; R Whitener; K E Thummel; W Burke
Journal:  Clin Pharmacol Ther       Date:  2011-03       Impact factor: 6.875

9.  Primary care physicians' knowledge of and experience with pharmacogenetic testing.

Authors:  S B Haga; W Burke; G S Ginsburg; R Mills; R Agans
Journal:  Clin Genet       Date:  2012-07-03       Impact factor: 4.438

10.  Survey of US public attitudes toward pharmacogenetic testing.

Authors:  S B Haga; J M O'Daniel; G M Tindall; I R Lipkus; R Agans
Journal:  Pharmacogenomics J       Date:  2011-02-15       Impact factor: 3.550

View more
  11 in total

1.  Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.

Authors:  R P McKillip; B A Borden; P Galecki; S A Ham; L Patrick-Miller; J P Hall; S Hussain; K Danahey; M Siegler; M J Sorrentino; Y Sacro; A M Davis; D T Rubin; K Lipstreuer; T S Polonsky; R Nanda; W R Harper; J L Koyner; D L Burnet; W M Stadler; M J Ratain; D O Meltzer; P H O'Donnell
Journal:  Clin Pharmacol Ther       Date:  2017-04-04       Impact factor: 6.875

2.  Democratizing Precision Medicine Through Community Engagement.

Authors:  Alison E Fohner; Kyle G Volk; Erica L Woodahl
Journal:  Clin Pharmacol Ther       Date:  2019-06-17       Impact factor: 6.875

3.  "Getting off the Bus Closer to Your Destination": Patients' Views about Pharmacogenetic Testing.

Authors:  Susan Brown Trinidad; Tara B Coffin; Stephanie M Fullerton; James Ralston; Gail P Jarvik; Eric B Larson
Journal:  Perm J       Date:  2015-06-01

4.  Tribal Deliberations about Precision Medicine Research: Addressing Diversity and Inequity in Democratic Deliberation Design and Evaluation.

Authors:  Erika Blacksher; Susan Brown Trinidad; R Brian Woodbury; Scarlett E Hopkins; Erica L Woodahl; Bert B Boyer; Wylie Burke; Vanessa Hiratsuka
Journal:  J Empir Res Hum Res Ethics       Date:  2022-02-28       Impact factor: 1.978

5.  Partnership with the Confederated Salish and Kootenai Tribes: Establishing an Advisory Committee for Pharmacogenetic Research.

Authors:  Chelsea T Morales; LeeAnna I Muzquiz; Kevin Howlett; Bernie Azure; Brenda Bodnar; Vernon Finley; Tony Incashola; Cheryl Mathias; Cindi Laukes; Patrick Beatty; Wylie Burke; Mark A Pershouse; Elizabeth A Putnam; Susan Brown Trinidad; Rosalina James; Erica L Woodahl
Journal:  Prog Community Health Partnersh       Date:  2016

6.  Primary Care Clinicians Attitudes and Knowledge of Pharmacogenetics in a Large, Multi-state, Healthcare System.

Authors:  Megan Olander; Stephen Waring; David D Stenehjem; Allise Taran; Paul Ranelli; Jacob T Brown
Journal:  Innov Pharm       Date:  2018-04-25

Review 7.  A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease.

Authors:  Stephanie Best; Nada Vidic; Kim An; Felicity Collins; Susan M White
Journal:  Eur J Hum Genet       Date:  2022-01-20       Impact factor: 5.351

8.  Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.

Authors:  Kelsey S Lau-Min; Lisa A Varughese; Maria N Nelson; Christine Cambareri; Nandi J Reddy; Randall A Oyer; Ursina R Teitelbaum; Sony Tuteja
Journal:  BMC Cancer       Date:  2022-01-08       Impact factor: 4.638

9.  Patients' Perceptions of Pharmacogenetic Testing and Access to Their Results: State of the Art in Spain and Systematic Review.

Authors:  Pablo Zubiaur; David Nicolás Prósper-Cuesta; Jesús Novalbos; Gina Mejía-Abril; Marcos Navares-Gómez; Gonzalo Villapalos-García; Paula Soria-Chacartegui; Francisco Abad-Santos
Journal:  J Pers Med       Date:  2022-02-12

10.  Current developments in delivering customized care: a scoping review.

Authors:  Etienne Minvielle; Aude Fourcade; Thomas Ricketts; Mathias Waelli
Journal:  BMC Health Serv Res       Date:  2021-06-13       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.